Want to see IN:ASTERDM full AI Analyst Report?
Top Page
Aster DM Healthcare Ltd.
(ASTERDM)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹749.00
▲(21.75% Upside)
Action:Reiterated
Date:08/06/26
The score is primarily supported by improving but still inconsistent financial performance (better margins, lower leverage, and positive FY2026 free cash flow, offset by volatility in earnings quality and cash conversion). Technicals add support with a clear uptrend and positive momentum, while the overall score is held back by demanding valuation (very high P/E and low dividend yield).
Positive Factors
Integrated healthcare network
A broad, integrated healthcare platform can capture patient spending across inpatient, outpatient, diagnostics and pharmacy services. This diversified care model supports recurring patient flows, cross-service utilization and resilience across individual specialties or facility types over the next several quarters.
Negative Factors
Volatile earnings quality
Irregular revenue and profit patterns make it harder to establish a dependable baseline for future earnings. The unusually large FY2025 net income spike may not represent normalized operating performance, reducing confidence that reported profitability will remain consistent over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated healthcare network
A broad, integrated healthcare platform can capture patient spending across inpatient, outpatient, diagnostics and pharmacy services. This diversified care model supports recurring patient flows, cross-service utilization and resilience across individual specialties or facility types over the next several quarters.
Read all positive factors
Aster DM Healthcare Ltd. (ASTERDM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹610.13B
Dividend Yield0.57%
Average Volume (3M)156.52K
Price to Earnings (P/E)113.4
Beta (1Y)0.70
Revenue Growth15.70%
EPS Growth-2.76%
CountryIN
Employees15,773
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)6.17
Shares Outstanding871,672,400
10 Day Avg. Volume147,689
30 Day Avg. Volume156,516
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹910.00Price Target Upside47.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)14.39
Revenue Forecast (FY)₹101.97B
Aster DM Healthcare Ltd. Business Overview & Revenue Model
Company Description
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified ser...
How the Company Makes Money
Aster DM Healthcare Ltd. generates revenue primarily by delivering healthcare services through its owned and operated facilities. Key revenue streams typically include: (1) Inpatient hospital revenue: earnings from admissions, bed/room charges, op...
Aster DM Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
67
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.76B | 46.43B | 40.69B | 36.38B | 29.52B | 102.53B |
| Gross Profit | 20.68B | 14.23B | 31.31B | 27.22B | 21.68B | 73.62B |
| EBITDA | 9.19B | 9.57B | 8.33B | 5.87B | 10.61B | 15.34B |
| Net Income | 3.19B | 3.88B | 53.78B | 1.29B | 4.25B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 81.12B | 66.06B | 179.91B | 148.81B | 125.46B |
| Cash, Cash Equivalents and Short-Term Investments | 13.27B | 13.27B | 13.81B | 1.11B | 3.96B | 3.69B |
| Total Debt | 0.00 | 22.20B | 20.18B | 13.84B | 57.00B | 49.07B |
| Total Liabilities | -48.34B | 32.78B | 29.55B | 129.61B | 100.21B | 80.64B |
| Stockholders Equity | 48.34B | 45.76B | 34.28B | 45.60B | 44.48B | 39.53B |
Cash Flow | ||||||
| Free Cash Flow | 873.00M | 2.01B | 790.10M | -6.39B | 9.86B | 7.65B |
| Operating Cash Flow | 3.19B | 6.71B | 4.25B | 1.58B | 18.34B | 13.13B |
| Investing Cash Flow | -747.80M | -4.36B | 60.15B | -8.85B | -9.72B | -5.70B |
| Financing Cash Flow | -2.14B | -1.72B | -63.58B | 10.53B | -8.17B | -6.85B |
Aster DM Healthcare Ltd. Technical Analysis
Negative
615.20
Price Trends
772.77
Negative
777.31
Negative
709.46
Negative
Market Momentum
-24.10
Positive
37.88
Neutral
11.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ASTERDM, the sentiment is Negative. The current price of 615.2 is below the 20-day moving average (MA) of 732.24, below the 50-day MA of 772.77, and below the 200-day MA of 709.46, indicating a bearish trend. The MACD of -24.10 indicates Positive momentum. The RSI at 37.88 is Neutral, neither overbought nor oversold. The STOCH value of 11.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ASTERDM.
Aster DM Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹353.27B | 63.42 | ― | 0.08% | 21.27% | 4.09% | |
64 Neutral | ₹610.13B | 113.43 | ― | 0.57% | 15.70% | -2.76% | |
62 Neutral | ₹351.41B | 42.86 | ― | 0.26% | 57.80% | 4.07% | |
60 Neutral | ₹592.72B | 56.65 | ― | 0.13% | 17.50% | 20.65% | |
59 Neutral | ₹1.15T | 55.23 | ― | 0.25% | 17.20% | 32.79% | |
55 Neutral | ₹860.41B | 59.04 | ― | 0.23% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:ASTERDM
Aster DM Healthcare Ltd.
699.95
-0.65
-0.09%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,020.00
363.70
4.75%
IN:FORTIS
Fortis Healthcare Ltd.
785.10
-309.34
-28.26%
IN:MAXHEALTH
Max Healthcare Institute Ltd
884.00
-257.82
-22.58%
IN:MEDANTA
Global Health Limited
1,313.90
-47.17
-3.47%
IN:NH
Narayana Hrudayalaya Ltd.
1,719.55
-35.75
-2.04%
Aster DM Healthcare Ltd. Corporate Events
Aster DM Quality Care Secures Shareholder Nod on Postal Ballot Resolutions
Sep 26, 2026
Aster DM Quality Care Limited, formerly Aster DM Healthcare Limited, is a publicly listed healthcare services provider in India, trading under the symbol ASTERDM on major domestic exchanges. Its broad shareholder base and adherence to SEBI’s...
Aster DM Quality Care Closes Trading Window Ahead of September Quarter Results
Sep 26, 2026
Aster DM Quality Care Limited has announced the closure of its trading window for designated persons and their immediate relatives starting 1 October 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’...
Aster DM Quality Care Calls Remote AGM, Releases FY 2025-26 Integrated Report
Sep 4, 2026
Aster DM Quality Care Limited has released its Integrated Annual Report for the financial year 2025-26 and issued notice convening its 18th Annual General Meeting on 28 September 2026. The AGM will be conducted via video conferencing and other aud...
Aster DM Quality Care Sets Virtual AGM for September 28, 2026
Sep 2, 2026
Aster DM Quality Care Limited has announced that its 18th Annual General Meeting will be held on 28 September 2026 at 11:30 a.m. IST via video conferencing and other audio-visual means, in line with regulatory allowances for virtual shareholder me...
Aster DM Quality Care to Merge Hospitality Subsidiaries for Structural, Operational Gains
Aug 29, 2026
Aster DM Quality Care Limited has announced that the boards of its step-down subsidiaries KIMSHEALTH Executive Leisure Private Limited and Spiceretreat Hospitality Services Private Limited have approved a scheme of amalgamation, with KEL merging i...
Aster DM Quality Care Posts Q1 FY27 Earnings Call Recording Online
Aug 5, 2026
Aster DM Quality Care Limited has announced that the video and audio recording of its earnings call for the quarter ended June 30, 2026, held on August 5, 2026, is now accessible on the company’s website. This disclosure, made under SEBI lis...
Aster DM Quality Care Board Clears Q1 FY27 Unaudited Results After Clean Auditor Review
Aug 5, 2026
Aster DM Quality Care Limited’s Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, following review and recommendation by its Audit Committee. The results, prepared...
Aster DM Quality Care Schedules Q1 FY27 Earnings Call for Analysts and Investors
Jul 31, 2026
Aster DM Quality Care Limited has announced that it will hold an earnings conference call with analysts and investors on Wednesday, 5 August 2026, at 6:00 p.m. IST to discuss its unaudited financial results for the quarter ended 30 June 2026. The ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.